Investing in Life Science

Company showcases

Experience dynamic, concise presentations from pioneering life science innovators, showcasing cutting-edge advancements and transformative trends shaping the industry’s future. Engage directly with these trailblazers in interactive Q&A sessions, gaining exclusive insights to inform your strategic decisions. Don’t miss this premier opportunity to connect, learn, and invest in the next wave of life science innovation.

A Premier Venue

BioStock will host Investing in Life Science – From Seed to Success at the prestigious IVA Conference Centre, nestled in the heart of Stockholm’s historic quarters. This iconic venue seamlessly blends the city’s timeless charm with state-of-the-art facilities, creating an inspiring backdrop for transformative connections. Engage in unparalleled networking and collaboration with leading innovators, investors, and industry experts in a sophisticated setting designed to spark innovation and drive the future of life science.

📍Grev Turegatan 16

DNB Carnegie | Back Bay

DNB Carnegie | Back Bay is a unique integrated strategy and corporate and investment banking solution for global and emerging life science and healthcare companies.

We combine scientific and strategic expertise with financing origination and execution to support healthcare companies of all sizes through each stage of growth—from chemistry to commercialization. Learn more and subscribe for our market updates: www.bblsa.com/dnb-carnegie-back-bay-partnership

Nasdaq

With more than 90 pct. of all US biotech, pharma & life science companies listed on Nasdaq, we know how to match savvy investors with trail-blazing inventors.

We are here to support your ideas and the next steps to a public offering that keeps you in control while raising capital to ignite your ambition. By the way, if you want to keep your ambition closer to home, Nasdaq in the Nordic is the leading hub for listed biotech and health care companies in Europe, with strong support from investors and innovation communities across the region.

How to join the Nasdaq family? – Read more here.

Potter Clarkson

Potter Clarkson is one of Europe’s leading full-service IP law firms. 

Our sole objective is to help innovators and investors maximise the value of their business or investments by identifying, protecting, exploiting, and enforcing the required IP rights anywhere in the world.

With regards to biotechnology and the life sciences, our team is one of Europe’s largest.  We are fiercely proud of our reputation as the European IP firm of choice for clients of all sizes, from ambitious start-ups and SMEs through to Big Pharma.

Having worked alongside investors in the Nordics, Germany, and the UK for decades we also know to deliver the comprehensive and commercial view of the IP in an investment required to support the best investment decisions.